Consolidated Cash Flow Statements (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Cash flows from operating activities:
Net income	$ 194,490	$ 114,345	$ 108,459
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	59,355	50,174	55,279
Loss on debt extinguishment	52,450
Asset impairment and loss on sale of assets	33,676	2,549	16,574
Share-based compensation	12,374	11,241	12,177
Provision for inventory obsolescence	5,085	1,160	3,210
Pension funding less than (greater than) pension expense	593	3,812	(4,289)
Tax deficiency (benefit) related to share-based compensation	(4,119)	(1,790)	110
Income from equity method investment	(9,704)	(13,169)	(11,940)
Gain on sale of businesses and tangible assets	(134,480)		(44,847)
Deferred income tax expense (benefit)	(42,750)	2,294	(11,577)
Non-cash loss on derivatives and hedging instruments			2,893
Changes in operating assets and liabilities, net of the effects of currency exchange rate changes and acquired businesses:
Receivables	5,628	4,680	(39,458)
Inventories	31,706	(22,873)	(14,031)
Accounts payable	(55,166)	9,281	38,513
Accrued liabilities	(681)	12,317	(8,203)
Accrued taxes	(10,760)	(55)	(3,793)
Other assets	968	12,219	27,209
Other liabilities	723	(1,622)	(14,737)
Net cash provided by operating activities	139,388	184,563	111,549
Cash flows from investing activities:
Cash used to acquire businesses, net of cash acquired	(860,353)	(60,519)	(119,110)
Capital expenditures	(41,010)	(40,053)	(28,194)
Proceeds from disposal of businesses and tangible assets, net of cash sold	309,423	1,213	138,952
Net cash used for investing activities	(591,940)	(99,359)	(8,352)
Cash flows from financing activities:
Borrowings under credit arrangements	1,149,966
Payments under borrowing arrangements	(593,864)		(46,268)
Payments under share repurchase program	(75,000)	(50,000)
Debt issuance costs paid	(15,414)	(3,296)
Cash dividends paid	(11,441)	(9,410)	(9,412)
Proceeds from exercise of stock options	2,372	4,599	3,158
Proceeds from settlement of derivatives	4,024		4,217
Tax benefit (deficiency) related to share-based compensation	4,119	1,790	(110)
Net cash provided by (used for) financing activities	464,762	(56,317)	(48,415)
Effect of foreign currency exchange rate changes on cash and cash equivalents	333	(4,988)	(5,008)
Increase in cash and cash equivalents	12,543	23,899	49,774
Cash and cash equivalents, beginning of period	382,552	358,653	308,879
Cash and cash equivalents, end of period	$ 395,095	$ 382,552	$ 358,653